ABUS vs BIIB: Which Stock is Better?
Side-by-side comparison of Arbutus Biopharma Corp and Biogen Inc in 2026
ABUS
Arbutus Biopharma Corp
$4.53
BIIB
Biogen Inc
$184.87
Key Metrics Comparison
| Metric | ABUS | BIIB | Winner |
|---|---|---|---|
| Market Cap | $871.23M | $27.13B | BIIB |
| P/E Ratio | N/A | 21.42 | BIIB |
| EPS (TTM) | $N/A | $8.63 | BIIB |
| Revenue Growth | -0.6% | -0.1% | BIIB |
| Gross Margin | -98.9% | 78.9% | BIIB |
Analyze ABUS
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ABUS or BIIB a better investment?
Comparing ABUS and BIIB: Arbutus Biopharma Corp has a market cap of $871.23M while Biogen Inc has $27.13B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ABUS and BIIB?
ABUS (Arbutus Biopharma Corp) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ABUS or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ABUS or BIIB?
BIIB has higher revenue growth at -0.1% vs -0.6% for ABUS.
Which company is more profitable: ABUS or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to -98.9% for ABUS.
Which is the larger company: ABUS or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $27.13B compared to $871.23M for ABUS.
Should I buy ABUS or BIIB in 2026?
Both ABUS and BIIB have investment merit. ABUS trades at $4.53 while BIIB trades at $184.87. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ABUS and BIIB stock?
Key differences: Market Cap ($871.23M vs $27.13B), P/E Ratio (N/A vs 21.4x), Revenue Growth (-0.6% vs -0.1%), Gross Margin (-98.9% vs 78.9%).